Ian D. Fier

Corporate Officer/Principal presso MOMENTA PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profilo

Ian D.
Fier is currently the Chief Manufacturing & Program Officer at Momenta Pharmaceuticals, Inc. He previously worked as the Vice President-Clinical Affairs at BioTransplant, Inc. Fier holds an MBA degree from Boston University and an undergraduate degree from Tufts University.

Posizioni attive di Ian D. Fier

Società	Posizione	Inizio
MOMENTA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/10/2002

Tutte le posizioni attive di Ian D. Fier

Precedenti posizioni note di Ian D. Fier

Società	Posizione	Fine
BioTransplant, Inc. BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Ian D. Fier

Formazione di Ian D. Fier

Tufts University	Undergraduate Degree
Boston University	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ian D. Fier

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.	Health Technology
BioTransplant, Inc. BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA.	Health Technology